Clinical Trials
3 trialsNCT01087294 2026-06-01
Administration of Anti-CD19-chimeric-antigen-receptor-transduced T Cells From the Original Transplant Donor to Patients With Recurrent or Persistent B-cell Malignancies After Allogeneic Stem Cell Transplantation
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT03226704 2026-05-20
Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing
National Institutes of Health Clinical Center (CC)
Enrolling by invitation
NCT00899119 2013-12-18
Collecting Stem Cells in Patients With Waldenstrom's Macroglobulinemia
National Cancer Institute (NCI)
Unknown